UK markets closed

Evgen Pharma plc (EVG.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
0.77500.0000 (0.00%)
At close: 02:33PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 3.31M
Enterprise value -416.06k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.54
Price/book (mrq)0.84
Enterprise value/revenue -0.50
Enterprise value/EBITDA 0.10

Trading information

Stock price history

Beta (5Y monthly) 1.44
52-week change 3-79.87%
S&P500 52-week change 321.83%
52-week high 34.0500
52-week low 30.7000
50-day moving average 31.0010
200-day moving average 31.7903

Share statistics

Avg vol (3-month) 31.65M
Avg vol (10-day) 31.27M
Shares outstanding 5427.35M
Implied shares outstanding 6298.45M
Float 8229.95M
% held by insiders 127.61%
% held by institutions 127.80%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-368.43%

Management effectiveness

Return on assets (ttm)-45.52%
Return on equity (ttm)-60.57%

Income statement

Revenue (ttm)838k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -4.33M
Net income avi to common (ttm)-3.35M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.73M
Total cash per share (mrq)0.01
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)10.39
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-3.52M
Levered free cash flow (ttm)-2.81M